Leadership Team

Leadership Team

The leadership team at Akcea brings unmatched collective experience that is critical to guide the company’s focused effort to develop and commercialize its pipeline of therapies focused on serious and rare diseases. The team values a strong partnering ethos with physicians, patients, regulators and others in the industry, to advance critically needed therapies for the benefit of people living with these life-threatening diseases.

Damien McDevitt, Ph.D.

Interim Chief Executive Officer

Read Bio

Louis St. L. O’Dea, MB B.Ch. BAO, FRCP(C)

Chief Medical Officer

Read Bio

Mike MacLean

Chief Financial Officer

Read Bio

Kyle Jenne

Chief Commercial Officer

Read Bio

Kathleen Gallagher

VP, Corporate Communications and Investor Relations

Read Bio

Maura Bullock

VP, Human Resources

Read Bio

Molly Harper

Senior VP & Global Franchise General Manager

Read Bio

Richard Jones, Ph.D.

SVP, Head of Europe

Read Bio

Daniel Moynihan

Chief Compliance Officer

Read Bio

Joshua Patterson

VP, Legal

Read Bio

Michael Pollock

VP, Market Access

Read Bio

Michael W. Stevenson, R.Ph.,Ph.D.

VP, Medical Affairs

Read Bio